Jazz Pharmaceuticals plc Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation
Jazz Pharmaceuticals plc (JAZZ) reported Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation of $3.50 million for the 6-month period ending 2016-06-30, per its 10-Q filed 2016-08-09.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation · last filed 2016-08-09
- Jazz Pharmaceuticals plc adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2016-06-30 was -$4.43M.
- Jazz Pharmaceuticals plc adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2016-03-31 was $7.94M, a 25.36% decline year-over-year.
- Jazz Pharmaceuticals plc adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2015-03-31 was $10.63M, a 84.09% increase year-over-year.
- Jazz Pharmaceuticals plc adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2014-09-30 was $3.28M.
| Period end | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 3 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 6 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 9 month |
|---|---|---|---|
| 2016-06-30 | -$4.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $3.50M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $7.94M 10-Q · filed 2016-05-10 | ||
| 2015-09-30 | -$320.00K 10-Q · filed 2015-11-09 | ||
| 2015-03-31 | $10.63M 10-Q · filed 2016-05-10 | ||
| 2014-09-30 | $3.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$1.70M derived: sum of 2 quarters · filed 2015-11-09 | $4.08M 10-Q · filed 2015-11-09 |
| 2014-06-30 | -$4.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $792.00K 10-Q · filed 2015-08-05 | |
| 2014-03-31 | $5.78M 10-Q · filed 2015-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |